These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17681558)

  • 1. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
    Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
    Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
    Butelman ER; Harris TJ; Kreek MJ
    Psychopharmacology (Berl); 2004 Mar; 172(2):220-4. PubMed ID: 14586540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans.
    Butelman ER; Mandau M; Tidgewell K; Prisinzano TE; Yuferov V; Kreek MJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):300-6. PubMed ID: 17060493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.
    Baker LE; Panos JJ; Killinger BA; Peet MM; Bell LM; Haliw LA; Walker SL
    Psychopharmacology (Berl); 2009 Apr; 203(2):203-11. PubMed ID: 19153716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
    Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
    Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A.
    Peet MM; Baker LE
    Behav Pharmacol; 2011 Sep; 22(5-6):450-7. PubMed ID: 21814135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.
    Butelman ER; Rus S; Prisinzano TE; Kreek MJ
    Psychopharmacology (Berl); 2010 Jun; 210(2):253-62. PubMed ID: 20084367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats.
    Killinger BA; Peet MM; Baker LE
    Pharmacol Biochem Behav; 2010 Sep; 96(3):260-5. PubMed ID: 20493209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2005 May; 179(3):551-8. PubMed ID: 15682306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor.
    Sheffler DJ; Roth BL
    Trends Pharmacol Sci; 2003 Mar; 24(3):107-9. PubMed ID: 12628350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid.
    Butelman ER; Prisinzano TE; Deng H; Rus S; Kreek MJ
    J Pharmacol Exp Ther; 2009 Feb; 328(2):588-97. PubMed ID: 19001155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
    Braida D; Limonta V; Pegorini S; Zani A; Guerini-Rocco C; Gori E; Sala M
    Psychopharmacology (Berl); 2007 Mar; 190(4):441-8. PubMed ID: 17219220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.
    Johnson MW; MacLean KA; Reissig CJ; Prisinzano TE; Griffiths RR
    Drug Alcohol Depend; 2011 May; 115(1-2):150-5. PubMed ID: 21131142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
    Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
    J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
    Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
    Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
    Beerepoot P; Lam V; Luu A; Tsoi B; Siebert D; Szechtman H
    Neurosci Lett; 2008 Dec; 446(2-3):101-4. PubMed ID: 18824069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.